Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
暂无分享,去创建一个
K. Matthay | M. Hogarty | M. Haber | M. Norris | D. Tsao-Wei | Anasheh Shamirian | A. Marachelian | B. Hasenauer | R. Vemu | Yueh-Yun Chi | Andrea T Franson | Julie R. Park | David S Ziegler | Frank M Balis | Kangning Liu | Eugene W Gerner | Elizabeth Bruckheimer | Susan Groshen